Research amp Development for Patented Topical Drug Delivery Technology. Develop Rx,OTC amp Cosmeceutical products using proprietary delivery technology, Invisicare. Also market a line of anti aging skincare products using Invisicare through a wholly owned subsidiary Kintari Int. Inc. in both the US and Canada, see www.kintari.com
Quote | Skinvisible (OTCMKTS:SKVI)
Last: | $0.63 |
---|---|
Change Percent: | 0.0% |
Open: | $0.64 |
Close: | $0.63 |
High: | $0.64 |
Low: | $0.63 |
Volume: | 2,302 |
Last Trade Date Time: | 07/08/2024 03:00:00 am |
News | Skinvisible (OTCMKTS:SKVI)
Innovative Delivery System Shows Promise for GLP-1 Agonists, CB-1 Antagonists, and SGLT-2 Inhibitors LAS VEGAS, NV / ACCESSWIRE / June 24, 2024 / Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI ), an innovative topical / transdermal pharmaceutical research and development company, today anno...
TDCX Inc. American Depositary Shares each representing one Class A (TDCX) is expected to report for Q1 2024 nCino Inc. (NCNO) is expected to report $0 for Q1 2025 SK Telecom Co. Ltd. (SKM) is expected to report for Q1 2024 Redeia Corporacion S.A. ADR (RDEIY) is expected to report for ...
Message Board Posts | Skinvisible (OTCMKTS:SKVI)
Subject | By | Source | When |
---|---|---|---|
typical | Golden Cross | investorshub | 04/04/2023 10:40:22 PM |
Where did everybody go? | splintered sunlight | investorshub | 01/22/2023 7:16:16 PM |
anybody buying after today's news? | rhopton | investorshub | 06/06/2022 12:22:11 PM |
When it drops back down to .02 after | soldier543 | investorshub | 01/06/2019 12:55:45 PM |
SKVI: effective Jan. 4,2019 a one for 50 | Renee | investorshub | 01/03/2019 1:46:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Innovative Delivery System Shows Promise for GLP-1 Agonists, CB-1 Antagonists, and SGLT-2 Inhibitors LAS VEGAS, NV / ACCESSWIRE / June 24, 2024 / Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI ), an innovative topical / transdermal pharmaceutical research and development company, today anno...
TDCX Inc. American Depositary Shares each representing one Class A (TDCX) is expected to report for Q1 2024 nCino Inc. (NCNO) is expected to report $0 for Q1 2025 SK Telecom Co. Ltd. (SKM) is expected to report for Q1 2024 Redeia Corporacion S.A. ADR (RDEIY) is expected to report for ...
Administration of GLP-1 Receptor Agonists and CB-1 Receptor Antagonists Enhanced by Invisicare Topical / Transdermal Delivery System LAS VEGAS, NV / ACCESSWIRE / May 29, 2024 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB: SKVI ), an innovative pharmaceutical r...